WETS
CGEM icon

Wealth Enhancement Trust Services’s Cullinan Oncology CGEM Stock Holding History

Wealth Enhancement Trust Services’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44K Buy
+79
New +$1.17K ﹤0.01% 1050

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wealth Enhancement Trust Services's CGEM Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 79 shares worth $1.44K. The stake represents ﹤0.01% of the portfolio and ranks #1050 among its holdings.

99 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Wealth Enhancement Trust Services held 79 shares of Cullinan Oncology worth $1.44K as of Q2 2026.
  • Cullinan Oncology was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1050 holding.
  • 99 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.